Radiation therapy, because it effectively treats microscopic residual disease, has allowed multi-m odality approaches that expand the criteria for organ preservation. M y research effor ts in soft tissue sarcom a have focused on im proving rates of local control and lim iting norm al tissue toxicities by optim izing radiotherapeutic appro aches with brachytherapy and intraoperative irradiation. Brachytherapy has been used for de® nitive therapy of sarcomas that are newly diagnosed or that have recurred w ithin a previously irradiated area. D espite concerns about wound healing and radiation effects on sm all vessels, we have shown that the viab ility of myocutaneous¯ap reconstruction is not com prom ised by brachytherapy. Providing com parab le rates of local control, brachytherapy also proved to be an efficient, cost-effective alternative to conventional external beam radiation. F unction preservation is an integral issue in quality of life, especially am ong patients with recurrent sarcom a in w hich lim b-sp aring surg ical interventions are often facilitated by brachytherapy. Intraoperative irradiation and other techniques to exclude the sm all bowel from the external beam radiation portal have been applied to reduce risk of local recurrence in retroperitoneal sarcom as. Supportive care, that involves control of disease and treatmentrelated sym ptoms, has also been a research priority.
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